4/A
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-009164
CEO and CFO bought 3,500 shares at $12.49 ($43,715)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2024-03-05 | Purchase | +3,500 | $12.49 | $43,715 | 5,343,777 | D |
| Open-market purchases · 3,500 sh · avg $12.49 · $43,715 | |||||||
Loading xslF345X05/ownership.xml…